Cyproheptadine Hydrochloride NDC 71335-1107

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-1107Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-1107Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-1107-1	71335110701	30 TABLET in 1 BOTTLE (71335-1107-1)Marketed from Feb 21, 2019
71335-1107-2	71335110702	60 TABLET in 1 BOTTLE (71335-1107-2)Marketed from Feb 21, 2019
71335-1107-3	71335110703	28 TABLET in 1 BOTTLE (71335-1107-3)Marketed from Feb 21, 2019
71335-1107-4	71335110704	100 TABLET in 1 BOTTLE (71335-1107-4)Marketed from Feb 21, 2019
71335-1107-5	71335110705	90 TABLET in 1 BOTTLE (71335-1107-5)Marketed from Feb 21, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cyproheptadine Hydrochloride
Generic name (nonproprietary): cyproheptadine hydrochloride
Active ingredients: Cyproheptadine hydrochloride — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209172
Marketing start: Apr 11, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 71335-1107_9a366fac-a3ee-4ed0-926a-03f50fe853d5SPL ID 9a366fac-a3ee-4ed0-926a-03f50fe853d5SPL set ID ab58d4df-69d4-43ac-ac6c-871fcc6c946dRxCUI 866144UNII NJ82J0F8QC

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335110701 followed by a unit qualifier and the quantity

Package 71335-1107-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 28, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Perennial and seasonal allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma Cold urticaria Dermatographism As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209172

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209172
Product	Strength	Form · route	Labeler	Product NDC
Cyproheptadine Hydrochloride	Cyproheptadine hydrochloride 4 mg/1	TabletOral	Strides Pharma Science Limited	64380-795